BARROW NEUROLOGICAL FOUNDATION

Raises funds to advance neuroscience research and patient care, having raised over $135 million over 60 years and $50.1 million in fiscal year 2024. This includes specific fundraising for targeted research projects and the Ivy Brain Tumor Center.

Raised over $135 million across more than 60 years to advance neuroscience research and patient care, including $50.1 million in fiscal year 2024 alone to support life-saving innovation.

Has raised over $135 million across more than 60 years to support neuroscience research and patient care, including $50.1 million in fiscal year 2024 alone for life-saving innovation.

Raises significant financial resources to advance neuroscience research and improve patient care, having raised over $135 million in more than 60 years, including $50.1 million in fiscal year 2024 and $16.3 million for targeted research projects. Funds are directed to research laboratories and specialized centers.

Raises significant financial resources to advance neuroscience research and patient care, including $50.1 million in fiscal year 2024 and over $135 million cumulatively over more than 60 years. Net proceeds from events like the Barrow Open golf tournament are directed entirely to research initiatives such as the Barrow Golf Neuroscience Research Laboratory.

Hosts fundraising events such as the Barrow Open golf tournament, with 100% of net proceeds directed to the Barrow Golf Neuroscience Research Laboratory, supporting life-saving innovation through event-based philanthropy.

Hosts and directs 100% of net proceeds from the Barrow Open golf tournament to fund the Barrow Golf Neuroscience Research Laboratory, a dedicated mechanism for channeling event revenue into research.

Raised $5.1 million for the Ivy Brain Tumor Center through the 2026 Ball fundraising effort, demonstrating targeted capacity-building for specific neurological research initiatives.

Directs 100% of net proceeds from the Barrow Open golf tournament to fund the Barrow Golf Neuroscience Research Laboratory, raised $5.1 million for the Ivy Brain Tumor Center via the 2026 Ball, and established the Women's Board in 1964 to advance neurological research and care.

Conducts research to accelerate discoveries and transform neurological care, including refining cardiac standstill procedures, isolating genes for cerebral cavernous malformations, pioneering thoracoscopic spinal surgery, and generating evidence for early Alzheimer's diagnosis.

Conducts high-impact neuroscience research, including gene isolation for inherited cerebral cavernous malformations, refinement of surgical procedures, and clinical trials that generate evidence for early Alzheimer's diagnosis using PET scans. Research directly informs medical practice and insurance coverage policies.

Conducted groundbreaking research including refining the cardiac standstill procedure, isolating the gene for inherited cerebral cavernous malformations, pioneering thoracoscopic spinal surgery, and generating clinical trial evidence supporting PET scans for early Alzheimer's diagnosis and insurance coverage.

Conducts high-impact neuroscience research, including gene isolation for inherited cerebral cavernous malformations, refinement of surgical procedures, and clinical trials that generate evidence for early Alzheimer's diagnosis using PET scans. Research directly informs clinical practice and policy, such as insurance coverage.

Conducts high-impact research including gene isolation for inherited cerebral cavernous malformations, refinement of surgical procedures, and clinical trials that generate evidence for early Alzheimer's diagnosis using PET scans.

Provides direct patient care using innovative technologies such as minimally invasive spine surgery, robotic spine surgery, and microscopic techniques, including complex interventions like sealing cerebrospinal fluid leaks and managing neurocritical cases over extended ICU stays.

Provides cutting-edge direct patient care through minimally invasive spine surgery, robotic spine surgery, microscopic techniques, and neurocritical care. Includes complex diagnoses and treatments such as CSF leak identification, spinal surgery for fistula repair, and administration of experimental therapies leading to recovery from coma.

Delivers advanced neurological care using innovative technologies and procedures such as minimally invasive spine surgery, microscopic techniques, and robotic spine surgery. This includes diagnosing and treating complex conditions like Alzheimer's, CSF leaks, and providing critical care, experimental treatments, and rehabilitation services.

Delivers comprehensive, cutting-edge neurological care including minimally invasive spine surgery, robotic spine surgery, microscopic techniques, and FDA-approved compassionate-use treatments. Services include complex diagnostics (e.g., amyloid PET scans), neurocritical care, and surgical interventions for conditions like CSF leaks and brain tumors.

Delivers direct clinical services using innovative technologies and procedures such as minimally invasive spine surgery, microscopic techniques, robotic spine surgery, PET scanning for Alzheimer’s diagnosis, spinal surgery for CSF leaks, and administration of experimental treatments including compassionate-use drugs.

Established the Women's Board in 1964, a longstanding organizational body dedicated to advancing neurological research and care through sustained engagement and support.

Offers multidisciplinary rehabilitation services including psychological support, physical therapy, mindfulness, and yoga as part of pain management and recovery for neurological patients.